ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

164 hedge funds and large institutions have $129M invested in Esperion Therapeutics in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 44 reducing their positions, and 32 closing their positions.

Holders
164
Holders Change
–
Holders Change %
0%
% of All Funds
2.63%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
34
Increased
63
Reduced
44
Closed
32
Calls
$5.09M
Puts
$2.17M
Net Calls
+$2.91M
Net Calls Change
-$33.1M

Top Buyers

1
WA
1
Wasatch Advisors
Utah
$21.2M
2
AC
2
Armistice Capital
New York
$5.85M
3
TCM
3
Tang Capital Management
California
$2.94M
4
Millennium Management
4
Millennium Management
New York
$5.84M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$7.59M

Top Sellers

1
DTC
1
Deep Track Capital
Connecticut
$0
2
ACM
2
Altium Capital Management
New York
$0
3
B
3
Braidwell
Connecticut
$1.93M
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$0
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
201
Concourse Financial Group Securities
Alabama
– – – –
FWM
202
Focused Wealth Management
New York
– – – –
HT
203
HAP Trading
New York
– – – –
Wolverine Trading
204
Wolverine Trading
Illinois
– – – –
AAA
205
Affinity Asset Advisors
New York
– – – –
CM
206
Caption Management
Oklahoma
– – – –
5 6 7 8
9